11-10563981-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006691.4(LYVE1):āc.356C>Gā(p.Pro119Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000123 in 1,614,142 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006691.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LYVE1 | NM_006691.4 | c.356C>G | p.Pro119Arg | missense_variant | 3/6 | ENST00000256178.8 | |
IRAG1-AS1 | NR_046374.1 | n.308-22046G>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LYVE1 | ENST00000256178.8 | c.356C>G | p.Pro119Arg | missense_variant | 3/6 | 1 | NM_006691.4 | P1 | |
IRAG1-AS1 | ENST00000663840.1 | n.285+22439G>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000676 AC: 17AN: 251350Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135834
GnomAD4 exome AF: 0.000122 AC: 179AN: 1461886Hom.: 0 Cov.: 32 AF XY: 0.000124 AC XY: 90AN XY: 727246
GnomAD4 genome AF: 0.000125 AC: 19AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74442
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 30, 2021 | The c.356C>G (p.P119R) alteration is located in exon 3 (coding exon 3) of the LYVE1 gene. This alteration results from a C to G substitution at nucleotide position 356, causing the proline (P) at amino acid position 119 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at